Cabot (NYSE:CBT) Sets New 1-Year High – Here’s What Happened

Cabot Corporation (NYSE:CBT) reached a new 52-week high during trading on Tuesday . The stock traded as high as $90.07 and last traded at $89.0090, with a volume of 16849 shares changing hands. The stock had previously closed at $89.21.

Analyst Ratings Changes

Several research firms have recently commented on CBT. Truist Financial began coverage on Cabot in a report on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective for the company. JPMorgan Chase & Co. increased their price objective on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a report on Wednesday, May 13th. UBS Group raised their target price on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Friday, May 8th. Mizuho raised their target price on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Finally, Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $83.80.

Cabot Stock Up 0.2%

The firm has a fifty day simple moving average of $80.88 and a 200-day simple moving average of $74.46. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. The firm has a market cap of $4.57 billion, a price-to-earnings ratio of 16.73, a P/E/G ratio of 11.61 and a beta of 0.82.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.47 by $0.14. The firm had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.31 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same period last year, the business posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, sell-side analysts expect that Cabot Corporation will post 6.34 EPS for the current year.

Cabot Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Friday, May 29th were given a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a yield of 2.1%. This is a boost from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date was Friday, May 29th. Cabot’s dividend payout ratio (DPR) is 35.73%.

Institutional Investors Weigh In On Cabot

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Cabot by 5.6% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock worth $155,315,000 after buying an additional 124,613 shares in the last quarter. State Street Corp lifted its holdings in shares of Cabot by 1.0% during the fourth quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock worth $134,256,000 after buying an additional 20,021 shares in the last quarter. American Century Companies Inc. lifted its holdings in shares of Cabot by 8.4% during the third quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock worth $137,300,000 after buying an additional 140,665 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Cabot by 4.8% during the first quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock worth $131,253,000 after buying an additional 79,499 shares in the last quarter. Finally, Bank of America Corp DE lifted its holdings in shares of Cabot by 3.9% during the third quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock worth $128,032,000 after buying an additional 63,080 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.